Are you Dr. Hutchinson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 30 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1560 N 115th St
Ste 106
Seattle, WA 98133Phone+1 206-368-1558Fax+1 206-368-5751- Is this information wrong?
Summary
- Dr. John Hutchinson, MD is a pulmonologist in Seattle, Washington. He is currently licensed to practice medicine in Washington, California, and Idaho.
Education & Training
- University of WashingtonFellowship, Pulmonary Disease and Critical Care Medicine, 1978 - 1979
- University of Oklahoma Health Sciences CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1977 - 1978
- Virginia Mason Franciscan HealthResidency, Internal Medicine, 1976 - 1977
- Virginia Mason Franciscan HealthResidency, Internal Medicine, 1973 - 1975
- Harvard Medical SchoolClass of 1973
Certifications & Licensure
- WA State Medical License 1974 - 2025
- CA State Medical License 2011 - 2019
- ID State Medical License 2009 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 26 citationsAugmented Responses to Ozone in Obese Mice Require IL-17A and Gastrin-Releasing Peptide.Joel A. Mathews, Nandini Krishnamoorthy, David I. Kasahara, John N. Hutchinson, Youngji Cho, Jeffrey D. Brand, Alison S. Williams, Allison P. Wurmbrand, Luiza Ribeiro,...> ;American Journal of Respiratory Cell and Molecular Biology. 2017 Sep 28
- 52 citationsThe use of quantitative cultures and antibody coating of bacteria to diagnose bacterial pneumonia by fiberoptic bronchoscopy.Richard H. Winterbauer, John F. Hutchinson, Reinhardt Gn, Sumida Se, Dearden B, Thomas Ca, Schneider Pw, Neeley E. Pardee, E H Morgan, Little Jw> ;The American Review of Respiratory Disease. 2015 May 14
- 54 citationsAzathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial.G Raghu, W J Depaso, K Cain, S P Hammar, C E Wetzel, D F Dreis, J Hutchinson, N E Pardee, R H Winterbauer> ;The American Review of Respiratory Disease. 1991 Aug 1
- Join now to see all